Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,675 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905). The Lymphoma Study Group of the Japan Clinical Oncology Group.
Takenaka T, Mikuni C, Miura A, Sasaki T, Suzuki H, Hotta T, Hirano M, Fukuhara S, Sugiyama H, Nasu K, Dohi H, Kozuru M, Tomonaga M, Tajima K, Niimi M, Fukuda H, Mukai K, Shimoyama M. Takenaka T, et al. Among authors: tajima k. Jpn J Clin Oncol. 2000 Mar;30(3):146-52. doi: 10.1093/jjco/hyd036. Jpn J Clin Oncol. 2000. PMID: 10798542 Clinical Trial.
Alternating combination chemotherapy COP (cyclophosphamide, vincristine, prednisone) and MP (melphalan, prednisone) in multiple myeloma: a multicenter phase II study (JCOG8906). Lymphoma Study Group of the Japan Clinical Oncology Group.
Takenaka T, Shirakawa S, Mikuni C, Sai T, Shimamoto Y, Araki K, Hirano M, Miura A, Ohno Y, Ichimaru M, Hanada S, Inaba S, Konishi H, Toki H, Tajima K, Niimi M, Fukuda H, Shimoyama M. Takenaka T, et al. Among authors: tajima k. Jpn J Clin Oncol. 1999 Oct;29(10):485-9. doi: 10.1093/jjco/29.10.485. Jpn J Clin Oncol. 1999. PMID: 10645803 Clinical Trial.
Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma: Japan Clinical Oncology Group Study 9004.
Tobinai K, Takeyama K, Arima F, Aikawa K, Kobayashi T, Hanada S, Kasai M, Ogura M, Sueoka E, Mukai K, Tajima K, Fukuda H, Shirakawa S, Hotta T, Masanori S; Lymphoma Study Group of the Japan Clinical Oncology Group. Tobinai K, et al. Among authors: tajima k. Cancer Sci. 2007 Sep;98(9):1350-7. doi: 10.1111/j.1349-7006.2007.00556.x. Epub 2007 Jul 19. Cancer Sci. 2007. PMID: 17640299 Free PMC article. Clinical Trial.
Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma.
Tada K, Kim SW, Asakura Y, Hiramoto N, Yakushijin K, Kurosawa S, Tajima K, Mori S, Heike Y, Tanosaki R, Maeshima AM, Taniguchi H, Furuta K, Kagami Y, Matsuno Y, Tobinai K, Takaue Y, Fukuda T. Tada K, et al. Among authors: tajima k. Am J Hematol. 2012 Aug;87(8):770-5. doi: 10.1002/ajh.23246. Epub 2012 May 28. Am J Hematol. 2012. PMID: 22641292 Free article. Clinical Trial.
The role of local radiotherapy following rituximab-containing chemotherapy in patients with transformed indolent B-cell lymphoma.
Nozaki K, Maruyama D, Maeshima AM, Tajima K, Itami J, Shichijo T, Yuda S, Suzuki T, Toyoda K, Yamauchi N, Makita S, Fukuhara S, Munakata W, Kobayashi Y, Taniguchi H, Izutsu K, Tobinai K. Nozaki K, et al. Among authors: tajima k. Eur J Haematol. 2021 Feb;106(2):213-220. doi: 10.1111/ejh.13539. Epub 2020 Nov 6. Eur J Haematol. 2021. PMID: 33098704 Free PMC article.
Neuroendocrine neoplasms of the lung: a prognostic spectrum.
Asamura H, Kameya T, Matsuno Y, Noguchi M, Tada H, Ishikawa Y, Yokose T, Jiang SX, Inoue T, Nakagawa K, Tajima K, Nagai K. Asamura H, et al. Among authors: tajima k. J Clin Oncol. 2006 Jan 1;24(1):70-6. doi: 10.1200/JCO.2005.04.1202. J Clin Oncol. 2006. PMID: 16382115
Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702. Lymphoma Study Group.
Kobayashi T, Tobinai K, Shimoyama M, Mikuni C, Konda S, Kozuru M, Araki K, Sai T, Fukuhara S, Matsumoto M, Aoki I, Deura K, Oyama A, Hotta T, Abe T, Toki H, Nagai M, Fukuda H, Niimi M, Yamaguchi N, Tajima K, Shirakawa S. Kobayashi T, et al. Among authors: tajima k. Jpn J Clin Oncol. 1999 Jul;29(7):340-8. doi: 10.1093/jjco/29.7.340. Jpn J Clin Oncol. 1999. PMID: 10470659 Clinical Trial.
1,675 results